Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Omthera Pharmaceuticals

Omthera Pharmaceuticals

A company developing therapies to treat dyslipidemia and cardiovascular disease

OverviewStructured DataIssuesContributorsActivity
Is a
Company
Company
Organization
Organization
AngelList URL
angel.co/omthera-ph...maceuticals
CIK Number
1,477,598
0
Company Operating Status
Closed
Crunchbase URL
crunchbase.com/organiz...euticals
Facebook URL
@AstraZenecaUSCommunityConnections
Headquarters
New Jersey
New Jersey
Industry
Biotechnology
Biotechnology
Healthcare
Healthcare
Medical software
Medical software
Cancer
Cancer
Technology
Technology
Biology
Biology
Investors
Sofinnova Partners
Sofinnova Partners
NEA (New Enterprise Associates)
NEA (New Enterprise Associates)
IRS Number
263,797,738
0
Latest Funding Round Date
March 14, 2011
Latest Funding Type
Series B Round
Series B Round
LinkedIn URL
@company/omthera-pharmaceuticals-inc-/about
Location
Princeton, New Jersey
Princeton, New Jersey
Patents Assigned (Count)
1
Pitchbook URL
pitchbook.com/profiles.../51676-75
Place of Incorporation
Delaware
Delaware
0
SIC Code
2,834
0
Exchange
New York Stock Exchange
New York Stock Exchange
Stock Symbol
OMTH
Total Funding Amount (USD)
40,400,000
Official Website
omthera.com
Wellfound ID
omthera-pharmaceuticals

Find more companies like Omthera Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.